Aldeyra Therapeutics Inc (ALDX)
3.95
-0.14
(-3.42%)
USD |
NASDAQ |
May 17, 16:00
3.95
0.00 (0.00%)
After-Hours: 20:00
Aldeyra Therapeutics 1 Year Total Returns (Daily): -59.90% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -59.90% |
May 16, 2024 | -59.18% |
May 15, 2024 | -59.16% |
May 14, 2024 | -58.96% |
May 13, 2024 | -63.58% |
May 10, 2024 | -63.15% |
May 09, 2024 | -61.60% |
May 08, 2024 | -61.82% |
May 07, 2024 | -60.55% |
May 06, 2024 | -61.02% |
May 03, 2024 | -59.14% |
May 02, 2024 | -58.64% |
May 01, 2024 | -58.33% |
April 30, 2024 | -58.66% |
April 29, 2024 | -57.50% |
April 26, 2024 | -56.67% |
April 25, 2024 | -56.61% |
April 24, 2024 | -58.31% |
April 23, 2024 | -60.98% |
April 22, 2024 | -60.78% |
April 19, 2024 | -62.67% |
April 18, 2024 | -62.06% |
April 17, 2024 | -61.79% |
April 16, 2024 | -62.93% |
April 15, 2024 | -60.15% |
Date | Value |
---|---|
April 12, 2024 | -57.37% |
April 11, 2024 | -57.65% |
April 10, 2024 | -58.86% |
April 09, 2024 | -55.21% |
April 08, 2024 | -55.71% |
April 05, 2024 | -51.49% |
April 04, 2024 | -52.77% |
April 03, 2024 | -57.78% |
April 02, 2024 | -64.25% |
April 01, 2024 | -67.07% |
March 28, 2024 | -64.26% |
March 27, 2024 | -65.78% |
March 26, 2024 | -67.66% |
March 25, 2024 | -68.11% |
March 22, 2024 | -64.02% |
March 21, 2024 | -60.83% |
March 20, 2024 | -60.75% |
March 19, 2024 | -62.25% |
March 18, 2024 | -63.18% |
March 15, 2024 | -64.28% |
March 14, 2024 | -64.76% |
March 13, 2024 | -58.69% |
March 12, 2024 | -58.15% |
March 11, 2024 | -54.74% |
March 08, 2024 | -50.88% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-80.62%
Minimum
Mar 16 2020
622.8%
Maximum
Mar 16 2021
18.03%
Average
-22.84%
Median
Aug 07 2019
1 Year Total Returns (Daily) Benchmarks
AbbVie Inc | 20.83% |
United Therapeutics Corp | 26.86% |
Heron Therapeutics Inc | 156.0% |
Esperion Therapeutics Inc | 34.09% |
FibroGen Inc | -93.27% |